Advertisement
Advertisement

SNY

SNY logo

Sanofi - ADR

41.60
USD
Sponsored
-0.18
-0.43%
Jun 23, 16:00 UTC -4
Closed
exchange

After-Market

41.56

-0.04
-0.08%

SNY Earnings Reports

Positive Surprise Ratio

SNY beat 32 of 41 last estimates.

78%

Next Report

Date of Next Report
Jul 30, 2026
Estimate for Q2 26 (Revenue/ EPS)
$11.39B
/
$1.88
Implied change from Q1 26 (Revenue/ EPS)
+8.39%
/
--
Implied change from Q2 25 (Revenue/ EPS)
+13.98%
/
+18.24%

Sanofi - ADR earnings per share and revenue

On Apr 23, 2026, SNY reported earnings of 1.88 USD per share (EPS) for Q1 26, beating the estimate of 1.80 USD, resulting in a 4.07% surprise. Revenue reached 10.51 billion, compared to an expected 10.67 billion, with a -1.49% difference. The market reacted with a +1.34% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of 1.88 USD, with revenue projected to reach 11.39 billion USD, implying an increase of 0.00% EPS, and increase of 8.39% in Revenue from the last quarter.
FAQ
For Q1 2026, Sanofi - ADR reported EPS of $1.88, beating estimates by 4.07%, and revenue of $10.51B, -1.49% below expectations.
The stock price moved up 1.34%, changed from $46.90 before the earnings release to $47.53 the day after.
The next earning report is scheduled for Jul 30, 2026.
Based on 3 analysts, Sanofi - ADR is expected to report EPS of $1.88 and revenue of $11.39B for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement